Chemoinformaics analysis of (1S,5S,8S)-4,4,8-Trimethyltricyclo[6.3.1.01,5]dodec-2-ene
| Molecular Weight | 204.357 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 14 |
| Exact Molecular Weight | 204.188 | nRing | 3 |
| Solubility: LogS | -3.961 | nHRing | 0 |
| Solubility: LogP | 5.16 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.507 |
| Synth | 5.621 |
| Natural Product Likeliness | 3.179 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.618 |
| MDCK | 0.0000175 |
| BBB | 0.173 |
| PPB | 0.897959 |
| VDSS | 1.036 |
| FU | 0.103608 |
| CYP1A2-inh | 0.118 |
| CYP1A2-sub | 0.744 |
| CYP2c19-inh | 0.224 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.181 |
| CYP2c9-sub | 0.312 |
| CYP2d6-inh | 0.622 |
| CYP2d6-sub | 0.212 |
| CYP3a4-inh | 0.931 |
| CYP3a4-sub | 0.332 |
| CL | 3.112 |
| T12 | 0.077 |
| hERG | 0.022 |
| Ames | 0.001 |
| ROA | 0.138 |
| SkinSen | 0.659 |
| Carcinogencity | 0.746 |
| EI | 0.502 |
| Respiratory | 0.893 |
| NR-Aromatase | 0.632 |
| Antiviral | Yes |
| Prediction | 0.905979 |